> top > docs > PMC:1283364 > spans > 40060-41373 > annotations

PMC:1283364 / 40060-41373 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T8806 0-2 PRP denotes We
T8807 8-12 VBD denotes used
T8808 3-7 RB denotes next
T8809 13-18 NN denotes ELISA
T8810 19-21 TO denotes to
T8811 22-29 VB denotes measure
T8812 30-35 JJ denotes total
T8813 36-38 NN denotes Aβ
T8814 39-41 IN denotes in
T8815 42-45 DT denotes the
T8816 46-52 NNS denotes brains
T8817 53-55 IN denotes of
T8818 56-60 DT denotes each
T8819 61-66 NN denotes group
T8820 67-69 TO denotes to
T8821 70-79 VB denotes determine
T8822 80-87 IN denotes whether
T8823 138-146 VBD denotes occurred
T8824 88-91 DT denotes any
T8825 92-98 NN denotes change
T8826 99-101 IN denotes in
T8827 102-105 DT denotes the
T8828 106-112 NN denotes amount
T8829 113-115 CC denotes or
T8830 116-126 NN denotes solubility
T8831 127-129 IN denotes of
T8832 130-137 NN denotes peptide
T8833 147-152 IN denotes while
T8834 179-189 VBN denotes suppressed
T8835 153-159 NN denotes APPswe
T8836 160-163 NN denotes ind
T8837 159-160 HYPH denotes /
T8838 164-174 NN denotes expression
T8839 175-178 VBD denotes was
T8840 189-190 . denotes .
T8841 190-383 sentence denotes Cortical homogenates were sequentially extracted to separate peptide into PBS-, SDS-, and FA-soluble fractions, then transgene-derived Aβ40 and Aβ42 were measured by human-specific ELISA [23].
T8842 191-199 JJ denotes Cortical
T8843 200-211 NNS denotes homogenates
T8844 230-239 VBN denotes extracted
T8845 212-216 VBD denotes were
T8846 217-229 RB denotes sequentially
T8847 345-353 VBN denotes measured
T8848 240-242 TO denotes to
T8849 243-251 VB denotes separate
T8850 252-259 NN denotes peptide
T8851 260-264 IN denotes into
T8852 265-268 NN denotes PBS
T8853 284-291 JJ denotes soluble
T8854 268-269 HYPH denotes -
T8855 269-271 , denotes ,
T8856 271-274 NN denotes SDS
T8857 274-275 HYPH denotes -
T8858 275-277 , denotes ,
T8859 277-280 CC denotes and
T8860 281-283 NN denotes FA
T8861 283-284 HYPH denotes -
T8862 292-301 NNS denotes fractions
T8863 301-303 , denotes ,
T8864 303-307 RB denotes then
T8865 308-317 NN denotes transgene
T8866 318-325 VBN denotes derived
T8867 317-318 HYPH denotes -
T8868 326-330 NN denotes Aβ40
T8869 331-334 CC denotes and
T8870 335-339 NN denotes Aβ42
T8871 340-344 VBD denotes were
T8872 354-356 IN denotes by
T8873 357-362 JJ denotes human
T8874 363-371 JJ denotes specific
T8875 362-363 HYPH denotes -
T8876 372-377 NN denotes ELISA
T8877 378-379 -LRB- denotes [
T8878 379-381 CD denotes 23
T8879 381-382 -RRB- denotes ]
T8880 382-383 . denotes .
T8881 383-535 sentence denotes In all animals harboring amyloid deposits, we found that the vast majority of Aβ (>99%) was extracted into the SDS and FA fractions (Figure 5A and 5B).
T8882 384-386 IN denotes In
T8883 430-435 VBD denotes found
T8884 387-390 DT denotes all
T8885 391-398 NNS denotes animals
T8886 399-408 VBG denotes harboring
T8887 409-416 NN denotes amyloid
T8888 417-425 NNS denotes deposits
T8889 425-427 , denotes ,
T8890 427-429 PRP denotes we
T8891 436-440 IN denotes that
T8892 476-485 VBN denotes extracted
T8893 441-444 DT denotes the
T8894 450-458 NN denotes majority
T8895 445-449 JJ denotes vast
T8896 459-461 IN denotes of
T8897 462-464 NN denotes Aβ
T8898 465-466 -LRB- denotes (
T8899 469-470 NN denotes %
T8900 466-467 SYM denotes >
T8901 467-469 CD denotes 99
T8902 470-471 -RRB- denotes )
T8903 472-475 VBD denotes was
T8904 486-490 IN denotes into
T8905 491-494 DT denotes the
T8906 506-515 NNS denotes fractions
T8907 495-498 NN denotes SDS
T8908 499-502 CC denotes and
T8909 503-505 NN denotes FA
T8910 516-517 -LRB- denotes (
T8911 524-526 NN denotes 5A
T8912 517-523 NN denotes Figure
T8913 527-530 CC denotes and
T8914 531-533 NN denotes 5B
T8915 533-534 -RRB- denotes )
T8916 534-535 . denotes .
T8917 535-756 sentence denotes Consistent with the filter trap results presented above, there were no significant differences in SDS- or FA-soluble Aβ between the 6 mo untreated cohort and either the 6 mo + 3 mo treated or 6 mo + 6 mo treated cohorts.
T8918 536-546 JJ denotes Consistent
T8919 599-603 VBD denotes were
T8920 547-551 IN denotes with
T8921 552-555 DT denotes the
T8922 568-575 NNS denotes results
T8923 556-562 NN denotes filter
T8924 563-567 NN denotes trap
T8925 576-585 VBN denotes presented
T8926 586-591 RB denotes above
T8927 591-593 , denotes ,
T8928 593-598 EX denotes there
T8929 604-606 DT denotes no
T8930 619-630 NNS denotes differences
T8931 607-618 JJ denotes significant
T8932 631-633 IN denotes in
T8933 634-637 NN denotes SDS
T8934 645-652 JJ denotes soluble
T8935 637-638 HYPH denotes -
T8936 639-641 CC denotes or
T8937 642-644 NN denotes FA
T8938 644-645 HYPH denotes -
T8939 653-655 NN denotes Aβ
T8940 656-663 IN denotes between
T8941 664-667 DT denotes the
T8942 683-689 NN denotes cohort
T8943 668-669 CD denotes 6
T8944 670-672 NN denotes mo
T8945 673-682 JJ denotes untreated
T8946 690-693 CC denotes and
T8947 694-700 CC denotes either
T8948 748-755 NNS denotes cohorts
T8949 701-704 DT denotes the
T8950 705-706 CD denotes 6
T8951 707-709 NN denotes mo
T8952 710-711 SYM denotes +
T8953 712-713 CD denotes 3
T8954 714-716 NN denotes mo
T8955 717-724 VBN denotes treated
T8956 725-727 CC denotes or
T8957 728-729 CD denotes 6
T8958 730-732 NN denotes mo
T8959 733-734 SYM denotes +
T8960 735-736 CD denotes 6
T8961 737-739 NN denotes mo
T8962 740-747 VBN denotes treated
T8963 755-756 . denotes .
T8964 756-913 sentence denotes However, brains of both 6 mo + 3 mo and 6 mo + 6 mo treated cohorts contained roughly twice as much PBS-soluble Aβ40 as untreated 6-mo-old mice (Figure 5C).
T8965 757-764 RB denotes However
T8966 825-834 VBD denotes contained
T8967 764-766 , denotes ,
T8968 766-772 NNS denotes brains
T8969 773-775 IN denotes of
T8970 776-780 CC denotes both
T8971 783-785 NN denotes mo
T8972 781-782 CD denotes 6
T8973 809-816 VBN denotes treated
T8974 786-787 SYM denotes +
T8975 788-789 CD denotes 3
T8976 790-792 NN denotes mo
T8977 793-796 CC denotes and
T8978 797-798 CD denotes 6
T8979 799-801 NN denotes mo
T8980 802-803 SYM denotes +
T8981 804-805 CD denotes 6
T8982 806-808 NN denotes mo
T8983 817-824 NNS denotes cohorts
T8984 835-842 RB denotes roughly
T8985 843-848 RB denotes twice
T8986 852-856 JJ denotes much
T8987 849-851 RB denotes as
T8988 869-873 NN denotes Aβ40
T8989 857-860 NN denotes PBS
T8990 860-861 HYPH denotes -
T8991 861-868 JJ denotes soluble
T8992 874-876 IN denotes as
T8993 877-886 JJ denotes untreated
T8994 896-900 NNS denotes mice
T8995 887-888 CD denotes 6
T8996 889-891 NN denotes mo
T8997 888-889 HYPH denotes -
T8998 892-895 JJ denotes old
T8999 891-892 HYPH denotes -
T9000 901-902 -LRB- denotes (
T9001 909-911 NN denotes 5C
T9002 902-908 NN denotes Figure
T9003 911-912 -RRB- denotes )
T9004 912-913 . denotes .
T9005 913-996 sentence denotes Levels of Aβ42 showed a similar trend, but did not reach statistical significance.
T9006 914-920 NNS denotes Levels
T9007 929-935 VBD denotes showed
T9008 921-923 IN denotes of
T9009 924-928 NN denotes Aβ42
T9010 936-937 DT denotes a
T9011 946-951 NN denotes trend
T9012 938-945 JJ denotes similar
T9013 951-953 , denotes ,
T9014 953-956 CC denotes but
T9015 957-960 VBD denotes did
T9016 965-970 VB denotes reach
T9017 961-964 RB denotes not
T9018 971-982 JJ denotes statistical
T9019 983-995 NN denotes significance
T9020 995-996 . denotes .
T9021 996-1313 sentence denotes In fact, levels of PBS-soluble Aβ40 and Aβ42 in the 6 mo + 3 mo and 6 mo + 6 mo treated cohorts were most similar to that of the 9 mo untreated cohort, suggesting that age, as opposed to synthetic rate (which would be negligible in the treated animals), may determine the fraction of PBS-soluble Aβ in these animals.
T9022 997-999 IN denotes In
T9023 1093-1097 VBD denotes were
T9024 1000-1004 NN denotes fact
T9025 1004-1006 , denotes ,
T9026 1006-1012 NNS denotes levels
T9027 1013-1015 IN denotes of
T9028 1016-1019 NN denotes PBS
T9029 1020-1027 JJ denotes soluble
T9030 1019-1020 HYPH denotes -
T9031 1028-1032 NN denotes Aβ40
T9032 1033-1036 CC denotes and
T9033 1037-1041 NN denotes Aβ42
T9034 1042-1044 IN denotes in
T9035 1045-1048 DT denotes the
T9036 1085-1092 NNS denotes cohorts
T9037 1049-1050 CD denotes 6
T9038 1051-1053 NN denotes mo
T9039 1054-1055 SYM denotes +
T9040 1056-1057 CD denotes 3
T9041 1058-1060 NN denotes mo
T9042 1061-1064 CC denotes and
T9043 1065-1066 CD denotes 6
T9044 1067-1069 NN denotes mo
T9045 1070-1071 SYM denotes +
T9046 1072-1073 CD denotes 6
T9047 1074-1076 NN denotes mo
T9048 1077-1084 VBN denotes treated
T9049 1098-1102 RBS denotes most
T9050 1103-1110 JJ denotes similar
T9051 1111-1113 IN denotes to
T9052 1114-1118 DT denotes that
T9053 1119-1121 IN denotes of
T9054 1122-1125 DT denotes the
T9055 1141-1147 NN denotes cohort
T9056 1126-1127 CD denotes 9
T9057 1128-1130 NN denotes mo
T9058 1131-1140 JJ denotes untreated
T9059 1147-1149 , denotes ,
T9060 1149-1159 VBG denotes suggesting
T9061 1160-1164 IN denotes that
T9062 1255-1264 VB denotes determine
T9063 1165-1168 NN denotes age
T9064 1168-1170 , denotes ,
T9065 1170-1172 IN denotes as
T9066 1173-1180 VBN denotes opposed
T9067 1181-1183 IN denotes to
T9068 1184-1193 JJ denotes synthetic
T9069 1194-1198 NN denotes rate
T9070 1199-1200 -LRB- denotes (
T9071 1200-1205 WDT denotes which
T9072 1212-1214 VB denotes be
T9073 1206-1211 MD denotes would
T9074 1215-1225 JJ denotes negligible
T9075 1226-1228 IN denotes in
T9076 1229-1232 DT denotes the
T9077 1241-1248 NNS denotes animals
T9078 1233-1240 VBN denotes treated
T9079 1248-1249 -RRB- denotes )
T9080 1249-1251 , denotes ,
T9081 1251-1254 MD denotes may
T9082 1265-1268 DT denotes the
T9083 1269-1277 NN denotes fraction
T9084 1278-1280 IN denotes of
T9085 1281-1284 NN denotes PBS
T9086 1285-1292 JJ denotes soluble
T9087 1284-1285 HYPH denotes -
T9088 1293-1295 NN denotes Aβ
T9089 1296-1298 IN denotes in
T9090 1299-1304 DT denotes these
T9091 1305-1312 NNS denotes animals
T9092 1312-1313 . denotes .
R6118 T8814 T8811 prep in,measure
R6123 T8815 T8816 det the,brains
R6127 T8816 T8814 pobj brains,in
R6129 T8817 T8816 prep of,brains
R6130 T8818 T8819 det each,group
R6133 T8819 T8817 pobj group,of
R6137 T8820 T8821 aux to,determine
R6140 T8821 T8811 advcl determine,measure
R6143 T8822 T8823 mark whether,occurred
R6145 T8806 T8807 nsubj We,used
R6146 T8808 T8807 advmod next,used
R6147 T8823 T8821 ccomp occurred,determine
R6148 T8809 T8807 dobj ELISA,used
R6149 T8810 T8811 aux to,measure
R6150 T8824 T8825 det any,change
R6151 T8811 T8807 advcl measure,used
R6152 T8812 T8813 amod total,Aβ
R6153 T8813 T8811 dobj Aβ,measure
R6154 T8825 T8823 nsubj change,occurred
R6155 T8826 T8825 prep in,change
R6156 T8827 T8828 det the,amount
R6157 T8828 T8826 pobj amount,in
R6158 T8829 T8828 cc or,amount
R6159 T8830 T8828 conj solubility,amount
R6160 T8920 T8918 prep with,Consistent
R6161 T8921 T8922 det the,results
R6162 T8831 T8828 prep of,amount
R6163 T8922 T8920 pobj results,with
R6164 T8923 T8922 compound filter,results
R6165 T8832 T8831 pobj peptide,of
R6166 T8924 T8922 compound trap,results
R6167 T8925 T8922 acl presented,results
R6168 T8926 T8925 advmod above,presented
R6169 T8833 T8834 mark while,suppressed
R6170 T8927 T8919 punct ", ",were
R6171 T8928 T8919 expl there,were
R6172 T8834 T8823 advcl suppressed,occurred
R6173 T8929 T8930 det no,differences
R6174 T8930 T8919 attr differences,were
R6175 T8931 T8930 amod significant,differences
R6176 T8835 T8836 compound APPswe,ind
R6177 T8932 T8930 prep in,differences
R6178 T8933 T8934 npadvmod SDS,soluble
R6179 T8836 T8838 compound ind,expression
R6180 T8934 T8939 amod soluble,Aβ
R6181 T8935 T8933 punct -,SDS
R6182 T8936 T8933 cc or,SDS
R6183 T8837 T8836 punct /,ind
R6184 T8937 T8933 conj FA,SDS
R6185 T8938 T8934 punct -,soluble
R6186 T8939 T8932 pobj Aβ,in
R6187 T8838 T8834 nsubjpass expression,suppressed
R6188 T8940 T8930 prep between,differences
R6189 T8941 T8942 det the,cohort
R6190 T8839 T8834 auxpass was,suppressed
R6191 T8942 T8940 pobj cohort,between
R6192 T8943 T8944 nummod 6,mo
R6193 T8944 T8942 nmod mo,cohort
R6194 T8840 T8807 punct .,used
R6195 T8945 T8942 amod untreated,cohort
R6196 T8946 T8942 cc and,cohort
R6197 T8947 T8948 preconj either,cohorts
R6198 T8948 T8942 conj cohorts,cohort
R6199 T8949 T8948 det the,cohorts
R6200 T8842 T8843 amod Cortical,homogenates
R6201 T8950 T8951 nummod 6,mo
R6202 T8951 T8948 nmod mo,cohorts
R6203 T8952 T8951 punct +,mo
R6204 T8843 T8844 nsubjpass homogenates,extracted
R6205 T8953 T8954 nummod 3,mo
R6206 T8954 T8951 appos mo,mo
R6207 T8955 T8954 acl treated,mo
R6208 T8844 T8847 ccomp extracted,measured
R6209 T8956 T8951 cc or,mo
R6210 T8957 T8958 nummod 6,mo
R6211 T8958 T8951 conj mo,mo
R6212 T8845 T8844 auxpass were,extracted
R6213 T8959 T8958 punct +,mo
R6214 T8960 T8961 nummod 6,mo
R6215 T8846 T8844 advmod sequentially,extracted
R6216 T8961 T8958 appos mo,mo
R6217 T8962 T8961 acl treated,mo
R6218 T8963 T8919 punct .,were
R6219 T8848 T8849 aux to,separate
R6220 T8965 T8966 advmod However,contained
R6221 T8849 T8844 advcl separate,extracted
R6222 T8850 T8849 dobj peptide,separate
R6223 T8967 T8966 punct ", ",contained
R6224 T8968 T8966 nsubj brains,contained
R6225 T8851 T8849 prep into,separate
R6226 T8969 T8968 prep of,brains
R6227 T8970 T8971 preconj both,mo
R6228 T8971 T8973 npadvmod mo,treated
R6229 T8852 T8853 npadvmod PBS,soluble
R6230 T8972 T8971 nummod 6,mo
R6231 T8973 T8983 amod treated,cohorts
R6232 T8853 T8862 amod soluble,fractions
R6233 T8974 T8971 punct +,mo
R6234 T8975 T8976 nummod 3,mo
R6235 T8854 T8852 punct -,PBS
R6236 T8976 T8971 appos mo,mo
R6237 T8977 T8971 cc and,mo
R6238 T8978 T8979 nummod 6,mo
R6239 T8855 T8852 punct ", ",PBS
R6240 T8979 T8971 conj mo,mo
R6241 T8980 T8979 punct +,mo
R6242 T8981 T8982 nummod 6,mo
R6243 T8856 T8852 conj SDS,PBS
R6244 T8982 T8979 appos mo,mo
R6245 T8983 T8969 pobj cohorts,of
R6246 T8857 T8856 punct -,SDS
R6247 T8984 T8985 advmod roughly,twice
R6248 T8985 T8986 advmod twice,much
R6249 T8986 T8988 amod much,Aβ40
R6250 T8987 T8986 advmod as,much
R6251 T8988 T8966 dobj Aβ40,contained
R6252 T8858 T8856 punct ", ",SDS
R6253 T8989 T8988 nmod PBS,Aβ40
R6254 T8990 T8988 punct -,Aβ40
R6255 T8991 T8988 amod soluble,Aβ40
R6256 T8859 T8856 cc and,SDS
R6257 T8992 T8988 prep as,Aβ40
R6258 T8993 T8994 amod untreated,mice
R6259 T8860 T8856 conj FA,SDS
R6260 T8994 T8992 pobj mice,as
R6261 T8995 T8996 nummod 6,mo
R6262 T8996 T8998 npadvmod mo,old
R6263 T8861 T8853 punct -,soluble
R6264 T8997 T8996 punct -,mo
R6265 T8998 T8994 amod old,mice
R6266 T8862 T8851 pobj fractions,into
R6267 T8999 T8998 punct -,old
R6268 T9000 T9001 punct (,5C
R6269 T8863 T8847 punct ", ",measured
R6270 T9001 T8966 parataxis 5C,contained
R6271 T9002 T9001 compound Figure,5C
R6272 T9003 T9001 punct ),5C
R6273 T8864 T8847 advmod then,measured
R6274 T9004 T8966 punct .,contained
R6275 T8865 T8866 npadvmod transgene,derived
R6276 T9006 T9007 nsubj Levels,showed
R6277 T9008 T9006 prep of,Levels
R6278 T8866 T8868 amod derived,Aβ40
R6279 T9009 T9008 pobj Aβ42,of
R6280 T9010 T9011 det a,trend
R6281 T8867 T8866 punct -,derived
R6282 T9011 T9007 dobj trend,showed
R6283 T9012 T9011 amod similar,trend
R6284 T9013 T9007 punct ", ",showed
R6285 T8868 T8847 nsubjpass Aβ40,measured
R6286 T9014 T9007 cc but,showed
R6287 T9015 T9016 aux did,reach
R6288 T8869 T8868 cc and,Aβ40
R6289 T9016 T9007 conj reach,showed
R6290 T9017 T9016 neg not,reach
R6291 T9018 T9019 amod statistical,significance
R6292 T8870 T8868 conj Aβ42,Aβ40
R6293 T9019 T9016 dobj significance,reach
R6294 T9020 T9007 punct .,showed
R6295 T8871 T8847 auxpass were,measured
R6296 T9022 T9023 prep In,were
R6297 T8872 T8847 agent by,measured
R6298 T9024 T9022 pobj fact,In
R6299 T8873 T8874 amod human,specific
R6300 T9025 T9023 punct ", ",were
R6301 T9026 T9023 nsubj levels,were
R6302 T8874 T8876 amod specific,ELISA
R6303 T9027 T9026 prep of,levels
R6304 T9028 T9029 npadvmod PBS,soluble
R6305 T9029 T9031 amod soluble,Aβ40
R6306 T8875 T8874 punct -,specific
R6307 T9030 T9029 punct -,soluble
R6308 T9031 T9027 pobj Aβ40,of
R6309 T8876 T8872 pobj ELISA,by
R6310 T9032 T9031 cc and,Aβ40
R6311 T9033 T9031 conj Aβ42,Aβ40
R6312 T9034 T9026 prep in,levels
R6313 T8877 T8878 punct [,23
R6314 T9035 T9036 det the,cohorts
R6315 T9036 T9034 pobj cohorts,in
R6316 T8878 T8847 parataxis 23,measured
R6317 T9037 T9038 nummod 6,mo
R6318 T9038 T9036 nmod mo,cohorts
R6319 T9039 T9038 punct +,mo
R6320 T8879 T8878 punct ],23
R6321 T9040 T9041 nummod 3,mo
R6322 T9041 T9038 appos mo,mo
R6323 T8880 T8847 punct .,measured
R6324 T9042 T9038 cc and,mo
R6325 T9043 T9044 nummod 6,mo
R6326 T9044 T9038 conj mo,mo
R6327 T8882 T8883 prep In,found
R6328 T9045 T9044 punct +,mo
R6329 T9046 T9047 nummod 6,mo
R6330 T9047 T9044 appos mo,mo
R6331 T9048 T9044 acl treated,mo
R6332 T8884 T8885 det all,animals
R6333 T9049 T9050 advmod most,similar
R6334 T9050 T9023 acomp similar,were
R6335 T9051 T9050 prep to,similar
R6336 T8885 T8882 pobj animals,In
R6337 T8886 T8885 acl harboring,animals
R6338 T9052 T9051 pobj that,to
R6339 T9053 T9052 prep of,that
R6340 T8887 T8888 compound amyloid,deposits
R6341 T9054 T9055 det the,cohort
R6342 T9055 T9053 pobj cohort,of
R6343 T9056 T9057 nummod 9,mo
R6344 T8888 T8886 dobj deposits,harboring
R6345 T9057 T9055 nmod mo,cohort
R6346 T9058 T9055 amod untreated,cohort
R6347 T8889 T8883 punct ", ",found
R6348 T9059 T9023 punct ", ",were
R6349 T9060 T9023 advcl suggesting,were
R6350 T8890 T8883 nsubj we,found
R6351 T9061 T9062 mark that,determine
R6352 T9062 T9060 ccomp determine,suggesting
R6353 T9063 T9062 nsubj age,determine
R6354 T9064 T9063 punct ", ",age
R6355 T9065 T9063 prep as,age
R6356 T9066 T9065 prep opposed,as
R6357 T8891 T8892 mark that,extracted
R6358 T9067 T9066 prep to,opposed
R6359 T9068 T9069 amod synthetic,rate
R6360 T8892 T8883 ccomp extracted,found
R6361 T9069 T9067 pobj rate,to
R6362 T9070 T9069 punct (,rate
R6363 T9071 T9072 dep which,be
R6364 T8893 T8894 det the,majority
R6365 T9072 T9069 relcl be,rate
R6366 T9073 T9072 aux would,be
R6367 T8894 T8892 nsubjpass majority,extracted
R6368 T9074 T9072 acomp negligible,be
R6369 T9075 T9072 prep in,be
R6370 T9076 T9077 det the,animals
R6371 T8895 T8894 amod vast,majority
R6372 T9077 T9075 pobj animals,in
R6373 T9078 T9077 amod treated,animals
R6374 T9079 T9062 punct ),determine
R6375 T8896 T8894 prep of,majority
R6376 T9080 T9062 punct ", ",determine
R6377 T9081 T9062 aux may,determine
R6378 T9082 T9083 det the,fraction
R6379 T8897 T8896 pobj Aβ,of
R6380 T9083 T9062 dobj fraction,determine
R6381 T9084 T9083 prep of,fraction
R6382 T8898 T8899 punct (,%
R6383 T9085 T9086 npadvmod PBS,soluble
R6384 T9086 T9088 amod soluble,Aβ
R6385 T9087 T9086 punct -,soluble
R6386 T8899 T8897 parataxis %,Aβ
R6387 T9088 T9084 pobj Aβ,of
R6388 T9089 T9062 prep in,determine
R6389 T9090 T9091 det these,animals
R6390 T8900 T8901 punct >,99
R6391 T9091 T9089 pobj animals,in
R6392 T9092 T9023 punct .,were
R6393 T8901 T8899 nummod 99,%
R6395 T8902 T8899 punct ),%
R6398 T8903 T8892 auxpass was,extracted
R6402 T8904 T8892 prep into,extracted
R6408 T8905 T8906 det the,fractions
R6411 T8906 T8904 pobj fractions,into
R6415 T8907 T8906 nmod SDS,fractions
R6418 T8908 T8907 cc and,SDS
R6422 T8909 T8907 conj FA,SDS
R6425 T8910 T8911 punct (,5A
R6429 T8911 T8892 parataxis 5A,extracted
R6431 T8912 T8911 compound Figure,5A
R6435 T8913 T8911 cc and,5A
R6438 T8914 T8911 conj 5B,5A
R6441 T8915 T8911 punct ),5A
R6442 T8916 T8883 punct .,found
R6443 T8918 T8919 advcl Consistent,were

2_test

Id Subject Object Predicate Lexical cue
16279840-11160418-86242774 379-381 11160418 denotes 23
T72545 379-381 11160418 denotes 23

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T6413 36-38 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T6414 46-52 UBERON:0000955 denotes brains
T6415 130-137 CHEBI_SO_EXT:peptide_or_peptide_region denotes peptide
T6416 164-174 GO:0010467 denotes expression
T6417 191-199 UBERON:0001851 denotes Cortical
T6418 252-259 CHEBI_SO_EXT:peptide_or_peptide_region denotes peptide
T6419 271-274 CHEBI:8984 denotes SDS
T6420 281-283 CHEBI:30751 denotes FA
T6421 308-317 SO_EXT:0000902 denotes transgene
T6422 326-330 CHEBI_PR_EXT:amyloid_beta_40 denotes Aβ40
T6423 335-339 CHEBI_PR_EXT:amyloid_beta_42 denotes Aβ42
T6424 357-362 NCBITaxon:9606 denotes human
T6425 391-398 NCBITaxon:33208 denotes animals
T6426 409-416 CHEBI:60425 denotes amyloid
T6427 462-464 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T6428 495-498 CHEBI:8984 denotes SDS
T6429 503-505 CHEBI:30751 denotes FA
T6430 634-637 CHEBI:8984 denotes SDS
T6431 642-644 CHEBI:30751 denotes FA
T6432 653-655 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T6433 766-772 UBERON:0000955 denotes brains
T6434 869-873 CHEBI_PR_EXT:amyloid_beta_40 denotes Aβ40
T6435 896-900 NCBITaxon:10088 denotes mice
T6436 924-928 CHEBI_PR_EXT:amyloid_beta_42 denotes Aβ42
T6437 1028-1032 CHEBI_PR_EXT:amyloid_beta_40 denotes Aβ40
T6438 1037-1041 CHEBI_PR_EXT:amyloid_beta_42 denotes Aβ42
T6439 1241-1248 NCBITaxon:33208 denotes animals
T6440 1293-1295 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T6441 1305-1312 NCBITaxon:33208 denotes animals

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T6046 46-52 UBERON:0000955 denotes brains
T6047 164-174 GO:0010467 denotes expression
T6048 191-199 UBERON:0001851 denotes Cortical
T6049 271-274 CHEBI:8984 denotes SDS
T6050 281-283 CHEBI:30751 denotes FA
T6051 308-317 SO:0000902 denotes transgene
T6052 357-362 NCBITaxon:9606 denotes human
T6053 391-398 NCBITaxon:33208 denotes animals
T6054 409-416 CHEBI:60425 denotes amyloid
T6055 495-498 CHEBI:8984 denotes SDS
T6056 503-505 CHEBI:30751 denotes FA
T6057 634-637 CHEBI:8984 denotes SDS
T6058 642-644 CHEBI:30751 denotes FA
T6059 766-772 UBERON:0000955 denotes brains
T6060 896-900 NCBITaxon:10088 denotes mice
T6061 1241-1248 NCBITaxon:33208 denotes animals
T6062 1305-1312 NCBITaxon:33208 denotes animals